Skip Navigation

European Heart Journal 1998 19(9):1294-1320; doi:10.1053/euhj.1998.1050
Copyright © 1998 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (162)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lévy, S.
Right arrow Articles by Lüderitz, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lévy, S.
Right arrow Articles by Lüderitz, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Atrial fibrillation: current knowledge and recommendations for management

S. Lévyf2, G. Breithardt, R.W.F. Campbell, A.J. Camm, DaubertJ.-C. , M. Allessie, E. Aliot, A. Capucci, F. Cosio, H. Crijns, L. Jordaens, R.N.W. Hauer, F. Lombardi and B. Lüderitz

on behalf of the Working Group on Arrhythmias of the The European Society of Cardiology

accepted March 12, 1998

Atrial fibrillation, a commonly encountered arrhythmia, has in recent years, been the subject of increased interest and intensive clinical research. There is also increasing awareness that atrial fibrillation is a major cause of embolic events which in 75% of cases are complicated by cerebrovascular accidents[1,2]. Atrial fibrillation is often associated with heart disease but a significant proportion of patients (about 30%) have no detectable heart disease[3]. Symptoms, occasionally disabling, haemo-dynamic impairment and a decrease in life expectancy are among the untoward effects of atrial fibrillation, resulting in an important morbidity, mortality and an increased cost for the health care provider[4].

The Working Group of Arrhythmias of the European Society of Cardiology created a Study Group on Atrial Fibrillation in order to establish recommen-dations for the better management of this arrhythmia and to promote multicentre studies. The purpose of this paper is to briefly outline the state of our knowledge on the clinical presentation, the causes, the mechanisms and therapeutic approaches currently available and to propose recommendations for management. Although atrial flutter can coexist with atrial fibrillation, it is considered a different arrhythmia and will not be covered in the present paper.

Key Words: atrial fibrillation • thromboembolism • anti-arrythmic agents • anticoagulant therapy

This Report represents the opinion of the Study Group on Atrial Fibrillation and does not necessarily reflect the opinion of the ESC.

f2 Correspondence:Samuel Lévy MD, FESC, Division of Cardiology, Hôpital Nord, Marseille, 13015 France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
F. G. Cosio, E. Aliot, G. L. Botto, H. Heidbuchel, C. J. Geller, P. Kirchhof, J.-C. De Haro, R. Frank, J. P. Villacastin, J. Vijgen, et al.
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
Europace, January 1, 2008; 10(1): 21 - 27.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E. B Friedrich and M. Bohm
MANAGEMENT OF END STAGE HEART FAILURE
Heart, May 1, 2007; 93(5): 626 - 631.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Milliez, N. DeAngelis, C. Rucker-Martin, A. Leenhardt, E. Vicaut, E. Robidel, P. Beaufils, C. Delcayre, and S. N. Hatem
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction
Eur. Heart J., October 2, 2005; 26(20): 2193 - 2199.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Kirchhof, G. Monnig, K. Wasmer, A. Heinecke, G. Breithardt, L. Eckardt, and D. Bocker
A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA)
Eur. Heart J., July 1, 2005; 26(13): 1292 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al.
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140.
[Full Text] [PDF]


Home page
QJMHome page
R. Mitra and E.W. Leatham
Admissions with atrial fibrillation: disease patterns and outcomes in a District General Hospital
QJM, February 1, 2005; 98(2): 153 - 154.
[Full Text] [PDF]


Home page
HeartHome page
L Boodhoo, G Bordoli, A R Mitchell, G Lloyd, N Sulke, and N Patel
The safety and effectiveness of a nurse led cardioversion service under sedation
Heart, December 1, 2004; 90(12): 1443 - 1446.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J L Martins, K F Fox, D A Wood, D C Lefroy, T J Collier, and N S Peters
Rapid access arrhythmia clinic for the diagnosis and management of new arrhythmias presenting in the community: a prospective, descriptive study
Heart, August 1, 2004; 90(8): 877 - 881.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R A Archbold and R J Schilling
Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature
Heart, February 1, 2004; 90(2): 129 - 133.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M Scholten, T Szili-Torok, P Klootwijk, and L Jordaens
Comparison of monophasic and biphasic shocks for transthoracic cardioversion of atrial fibrillation
Heart, September 1, 2003; 89(9): 1032 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G. Gronefeld, J.R. Ehrlich, and S.H. Hohnloser
Comparison of outpatient vs inpatient direct current cardioversion of atrial fibrillation: safety, efficacy and cost savings
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H19 - H24.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
P. Jais, D.C. Shah, M. Hocini, L. Macle, K.-J. Choi, M. Haissaguerre, and J. Clementy
Radiofrequency ablation for atrial fibrillation
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H34 - H39.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
G.Q. Villani, M. Piepoli, P.E. Villani, and A. Capucci
Anticoagulation in atrial fibrillation: what is certain and what is to come
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H45 - H50.
[Abstract] [PDF]


Home page
Eur Heart JHome page
P. Touboul, J. Brugada, A. Capucci, H. J.G.M. Crijns, N. Edvardsson, and S. H. Hohnloser
Dronedarone for prevention of atrial fibrillation: A dose-ranging study
Eur. Heart J., August 2, 2003; 24(16): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. Gronefeld and S. H. Hohnloser
Rhythm or Rate Control in Atrial Fibrillation: Insights from the Randomized Controlled Trials
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1_suppl): S39 - S44.
[Abstract] [PDF]


Home page
Postgrad. Med. J.Home page
S K S Lairikyengbam, M H Anderson, and A G Davies
Present treatment options for atrial fibrillation
Postgrad. Med. J., February 1, 2003; 79(928): 67 - 73.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Essebag, T. Hadjis, R. W. Platt, and L. Pilote
Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 249 - 254.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. Langerveld, N. M. van Hemel, J. C. Kelder, J. M. P. G. Ernst, H. W. M. Plokker, and W. Jaarsma
Long-term follow-up of cardiac rhythm after percutaneous mitral balloon valvotomy: Does atrial fibrillation persist?
Europace, January 1, 2003; 5(1): 47 - 53.
[Abstract] [PDF]


Home page
EuropaceHome page
S. Levy, A. J. Camm, S. Saksena, E. Aliot, G. Breithardt, H. Crijns, W. Davies, N. Kay, E. Prystowsky, R. Sutton, et al.
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology
Europace, January 1, 2003; 5(2): 119 - 122.
[PDF]


Home page
Nephrol Dial TransplantHome page
Z. Szabo, G. Kakuk, T. Fulop, J. Matyus, J. Balla, I. Karpati, A. Juhasz, C. Kun, Z. Karanyi, and I. Lorincz
Effects of haemodialysis on maximum P wave duration and P wave dispersion
Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1634 - 1638.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Deneke, K. Khargi, P. H. Grewe, S. von Dryander, F. Kuschkowitz, T. Lawo, K.-M. Muller, A. Laczkovics, and B. Lemke
Left atrial versus bi-atrial maze operation using intraoperatively cooled-tip radiofrequency ablation in patients undergoing open-heart surgery: Safety and efficacy
J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1644 - 1650.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Jais, R. Weerasooriya, D. C. Shah, M. Hocini, L. Macle, K.-J. Choi, C. Scavee, M. Haissaguerre, and J. Clementy
Ablation therapy for atrial fibrillation (AF): Past, present and future
Cardiovasc Res, May 1, 2002; 54(2): 337 - 346.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Olivotto, F. Cecchi, S. A. Casey, A. Dolara, J. H. Traverse, and B. J. Maron
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Circulation, November 20, 2001; 104(21): 2517 - 2524.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923.
[PDF]


Home page
Eur Heart JHome page
V. Frykman, B. Beerman, L. Ryden, and M. Rosenqvist
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications
Eur. Heart J., October 2, 2001; 22(20): 1954 - 1959.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force for the Diagnosis and Treatment of Chro, W. J. Remme, and K. Swedberg
Guidelines for the diagnosis and treatment of chronic heart failure
Eur. Heart J., September 1, 2001; 22(17): 1527 - 1560.
[PDF]


Home page
CirculationHome page
O. D. Pedersen, H. Bagger, N. Keller, B. Marchant, L. Kober, and C. Torp-Pedersen
Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy
Circulation, July 17, 2001; 104(3): 292 - 296.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
D.A. Wood, K.F. Fox, and S.R. Gibbs
Rapid cardiology--for chest pain, breathlessness and palpitations
QJM, April 1, 2001; 94(4): 177 - 178.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. H. Veloso
Long-term efficacy of epicardial radiofrequency ablation of chronic atrial fibrillation during mitral valve surgery
Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 231 - 232.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Lombardi, A. Colombo, B. Basilico, R. Ravaglia, M. Garbin, D. Vergani, P. M. Battezzati, and C. Fiorentini
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 157 - 162.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Poldermans, J. J. Bax, A. Elhendy, F. Sozzi, E. Boersma, I. R. Thomson, and L. J. Jordaens
Long-term Prognostic Value of Dobutamine Stress Echocardiography in Patients With Atrial Fibrillation
Chest, January 1, 2001; 119(1): 144 - 149.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Gasparini, A. Bonso, S. Themistoclakis, F. Giada, and A. Raviele
Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up
Europace, January 1, 2001; 3(2): 90 - 95.
[Abstract] [PDF]


Home page
EuropaceHome page
P. Ricard, S. Levy, G. Boccara, E. Lakhal, and G. Bardy
External cardioversion of atrial fibrillation: comparison of biphasic vs monophasic waveform shocks
Europace, January 1, 2001; 3(2): 96 - 99.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. P. Raatikainen, T. E. Morey, P. Druzgala, P. Milner, M. D. Gonzalez, and D. M. Dennis
Potent and Reversible Effects of ATI-2001 on Atrial and Atrioventricular Nodal Electrophysiological Properties in Guinea Pig Isolated Perfused Heart
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 779 - 785.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
D. Pfeiffer and B. Luderitz
The right atrial/transoesophagael approach for conversion of atrial fibrillation: a hybrid method for compromise?
Eur. Heart J., May 2, 2000; 21(10): 785 - 787.
[PDF]


Home page
Eur Heart JHome page
C. Stellbrink and P. Hanrath
The optimal management of cardioversion of atrial fibrillation of flutter: still a 'stunning' problem
Eur. Heart J., May 2, 2000; 21(10): 795 - 798.
[PDF]


Home page
CirculationHome page
E. R. Jessurun, N. M. van Hemel, J. A. M. T. Defauw, M. A. M. Stofmeel, J. C. Kelder, A. Brutel de la Riviere, and J. M. P. G. Ernst
Results of Maze Surgery for Lone Paroxysmal Atrial Fibrillation
Circulation, April 4, 2000; 101(13): 1559 - 1567.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland
Systematic review of the management of atrial fibrillation in patients with heart failure
Eur. Heart J., April 2, 2000; 21(8): 614 - 632.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S. Levy
Cardioversion of chronic atrial fibrillation--towards a more aggressive approach
Eur. Heart J., February 2, 2000; 21(4): 263 - 263.
[PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, L. E. Deelman, R. G. Tieleman, J. G. Grandjean, W. H. Van Gilst, and H. J.G.M. Crijns
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation
Cardiovasc Res, May 1, 1999; 42(2): 443 - 454.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Levy
Atrioventricular junctional ablation and pacing for paroxysmal atrial fibrillation: the Barcelona recommendations
Europace, January 1, 1999; 1(1): 2 - 4.
[PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.